PAULA MOCH: Open Payments
NPI 1851633804 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,505 in 73 payments from 24 companies in 2025. Trend: 2023 $1,481 · 2024 $1,625 · 2025 $1,505
Food & beverage: $1,505
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $226 |
| Regeneron Healthcare Solutions, Inc. | 9 | $160 |
| ABBVIE INC. | 9 | $140 |
| United Therapeutics Corporation | 6 | $109 |
| HARMONY BIOSCIENCES LLC | 5 | $105 |
| Baxter Healthcare | 4 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Aimmune Therapeutics, Inc. | 3 | $72 |
| Melinta Therapeutics, LLC | 3 | $63 |
| GlaxoSmithKline, LLC. | 4 | $62 |
Products named: BREZTRI, DUPIXENT, Tyvaso, WAKIX, Hillrom - Vest System Model 105 Home Care, Rezzayo, NUCALA, MOUNJARO.
Industry payments across ND — which companies pay providers there.
